From uncertainty to pathogenicity: clinical and functional interrogation of a rare TP53 in-frame deletion.
Ontology highlight
ABSTRACT: Li-Fraumeni syndrome (LFS) is a highly penetrant cancer predisposition syndrome caused by heterozygous germline mutations in the TP53 gene. Although more than 200 missense and null TP53 mutations are well established as disease-causing, little is known about the pathogenicity and cancer risks associated with small in-frame deletions. This leads to challenges in variant classification and subsequent difficulty making a molecular diagnosis. We report the genetic testing process for a pediatric patient diagnosed with an undifferentiated high-grade brain tumor following his mother's diagnosis of early-onset bilateral breast cancer. Sequential testing revealed that both harbored a heterozygous three-nucleotide deletion in exon 7 of TP53 (c.764_766delTCA; I255del), which was
SUBMITTER: Quinn EA
PROVIDER: S-EPMC6672031 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA